The Efficacy of Selective Laser Trabeculoplasty

The recruitment status of this study is unknown because the information has not been verified recently.

Verified June 2006 by Glaucoma Research & Education Group.
Recruitment status was Recruiting

Sponsor:

Collaborator:

PharmaLogic Development, Inc.

Information provided by:

Glaucoma Research & Education Group

ClinicalTrials.gov Identifier:

NCT00347893

First received: June 30, 2006

Last updated: NA

Last verified: June 2006

History: No changes posted

Tracking Information

First Received Date ^ICMJE

June 30, 2006

Last Updated Date

June 30, 2006

Start Date ^ICMJE

May 2006

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

No Changes Posted

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

The Efficacy of Selective Laser Trabeculoplasty

Official Title ^ICMJE

Clinical Results of Selective Laser Trabeculoplasty in Treatment of Open Angle Glaucoma

Brief Summary

Selective laser trabeculoplasty (SLT) is a new method to reduce intraocular pressure in eyes with open angle glaucoma or ocular hypertension. SLT may also be effective for cases with previously failed ALT procedures. We will study the efficacy and safety of the SLT procedure.

Detailed Description

Selective laser trabeculoplasty (SLT) has been shown to be a safe, well tolerated, and effective intraocular pressure reduction therapy for several forms of open-angle glaucoma. SLT produces significantly less disturbance to the trabecular meshwork and is theoretically more repeatable than the ALT procedure. This retrospective research will begin with cases treated in 2001. It will evaluate whether SLT is effective for patients who have had prior treatment with ALT and it will determine whether the IOP lowering effect is sustainable over time. It will also assess the efficacy of repeated SLT procedures.

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Retrospective

Target Follow-Up Duration

Not Provided

Biospecimen

Not Provided

Sampling Method

Not Provided

Study Population

Not Provided

Condition ^ICMJE

Primary Open Angle Glaucoma
Ocular Hypertension
Pseudo-Exfoliative Glaucoma
Pigment Dispersion Glaucoma

Intervention ^ICMJE

Procedure: Selective laser trabeculoplasty

Study Group/Cohort (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Enrollment ^ICMJE

Not Provided

Completion Date

Not Provided

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Patients with primary open angle glaucoma, ocular hypertension, pseudo exfoliative glaucoma, pigment dispersion glaucoma

Exclusion Criteria:

History of prior invasive glaucoma surgery

Gender

Both

Ages

Not Provided

Accepts Healthy Volunteers

Yes

Contacts ^ICMJE

Not Provided

Location Countries ^ICMJE

United States

Administrative Information

NCT Number ^ICMJE

NCT00347893

Other Study ID Numbers ^ICMJE

22222

Has Data Monitoring Committee

Not Provided

Responsible Party

Not Provided

Study Sponsor ^ICMJE

Glaucoma Research & Education Group

Collaborators ^ICMJE

PharmaLogic Development, Inc.

Investigators ^ICMJE

Principal Investigator:

Andrew G. Iwach, M.D.

Glaucoma Research & Education Group

Information Provided By

Glaucoma Research & Education Group

Verification Date

June 2006

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top